BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38178705)

  • 1. Macrophage expressed tartrate-resistant acid phosphatase 5 promotes pulmonary fibrosis progression.
    Bergwik J; Bhongir RKV; Padra M; Adler A; Olm F; Lång P; Lindstedt S; Andersson G; Egesten A; Tanner L
    Immunology; 2024 Apr; 171(4):583-594. PubMed ID: 38178705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tartrate-resistant acid phosphatase 5 promotes pulmonary fibrosis by modulating β-catenin signaling.
    Hu Y; Wang Q; Yu J; Zhou Q; Deng Y; Liu J; Zhang L; Xu Y; Xiong W; Wang Y
    Nat Commun; 2022 Jan; 13(1):114. PubMed ID: 35013220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of TIM-3 in Macrophages Aggravates Pathogenesis of Pulmonary Fibrosis in Mice.
    Wang Y; Kuai Q; Gao F; Wang Y; He M; Zhou H; Han G; Jiang X; Ren S; Yu Q
    Am J Respir Cell Mol Biol; 2019 Dec; 61(6):727-736. PubMed ID: 31162951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
    Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
    Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
    [No Abstract]   [Full Text] [Related]  

  • 5. Tartrate resistant acid phosphatase 5 (TRAP5) mediates immune cell recruitment in a murine model of pulmonary bacterial infection.
    Tanner L; Bergwik J; Bhongir RKV; Puthia M; Lång P; Ali MN; Welinder C; Önnerfjord P; Erjefält JS; Palmberg L; Andersson G; Egesten A
    Front Immunol; 2022; 13():1079775. PubMed ID: 36569898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of glutamine transporter ASCT2 mitigates bleomycin-induced pulmonary fibrosis in mice.
    Lian N; Jin H; Zhu W; Zhang C; Qi Y; Jiang M; Mao J; Lu X; Zhao F; Xi B; Qi X; Li Y
    Acta Histochem; 2022 Dec; 124(8):151961. PubMed ID: 36265204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical advance: The use of tree shrews as a model of pulmonary fibrosis.
    Larson-Casey JL; He C; Che P; Wang M; Cai G; Kim YI; El Hamdaoui M; Grytz R; Ding Q; Carter AB
    PLoS One; 2020; 15(11):e0241323. PubMed ID: 33141839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fra-2-expressing macrophages promote lung fibrosis in mice.
    Ucero AC; Bakiri L; Roediger B; Suzuki M; Jimenez M; Mandal P; Braghetta P; Bonaldo P; Paz-Ares L; Fustero-Torre C; Ximenez-Embun P; Hernandez AI; Megias D; Wagner EF
    J Clin Invest; 2019 May; 129(8):3293-3309. PubMed ID: 31135379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid DNA methyltransferase3b deficiency aggravates pulmonary fibrosis by enhancing profibrotic macrophage activation.
    Qin W; Spek CA; Scicluna BP; van der Poll T; Duitman J
    Respir Res; 2022 Jun; 23(1):162. PubMed ID: 35725453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo.
    Zhai X; Li J; Nie Y
    J Vis Exp; 2023 May; (195):. PubMed ID: 37212557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TREM2 Insufficiency Protects against Pulmonary Fibrosis by Inhibiting M2 Macrophage Polarization.
    Luo Q; Deng D; Li Y; Shi H; Zhao J; Qian Q; Wang W; Cai J; Yu W; Liu J
    Int Immunopharmacol; 2023 May; 118():110070. PubMed ID: 37003186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid-specific deletion of activating transcription factor 6 alpha increases CD11b
    Mekhael O; Revill SD; Hayat AI; Cass SP; MacDonald K; Vierhout M; Ayoub A; Reihani A; Padwal M; Imani J; Ayaub E; Yousof T; Dvorkin-Gheva A; Rullo A; Hirota JA; Richards CD; Bridgewater D; Stämpfli MR; Hambly N; Naqvi A; Kolb MR; Ask K
    Immunol Cell Biol; 2023 May; 101(5):412-427. PubMed ID: 36862017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of HtrA3 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via TGF-β1/Smad Signaling Pathway.
    Li G; Shen C; Wei D; Yang X; Jiang C; Yang X; Mao W; Zou J; Tan J; Chen J
    Lung; 2023 Apr; 201(2):235-242. PubMed ID: 36823409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A4
    Li Y; Bao J; Bian Y; Erben U; Wang P; Song K; Liu S; Li Z; Gao Z; Qin Z
    Front Immunol; 2018; 9():1776. PubMed ID: 30127784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classical monocyte-derived macrophages as therapeutic targets of umbilical cord mesenchymal stem cells: comparison of intratracheal and intravenous administration in a mouse model of pulmonary fibrosis.
    Choi SM; Mo Y; Bang JY; Ko YG; Ahn YH; Kim HY; Koh J; Yim JJ; Kang HR
    Respir Res; 2023 Mar; 24(1):68. PubMed ID: 36870972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VISTA (PD-1H) Is a Crucial Immune Regulator to Limit Pulmonary Fibrosis.
    Kim SH; Adams TS; Hu Q; Shin HJ; Chae G; Lee SE; Sharma L; Kwon HK; Lee FY; Park HJ; Huh WJ; Manning E; Kaminski N; Sauler M; Chen L; Song JW; Kim TK; Kang MJ
    Am J Respir Cell Mol Biol; 2023 Jul; 69(1):22-33. PubMed ID: 36450109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis.
    Barnes JW; Duncan D; Helton S; Hutcheson S; Kurundkar D; Logsdon NJ; Locy M; Garth J; Denson R; Farver C; Vo HT; King G; Kentrup D; Faul C; Kulkarni T; De Andrade JA; Yu Z; Matalon S; Thannickal VJ; Krick S
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L141-L154. PubMed ID: 31042083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of an immunotoxin to folate receptor beta on bleomycin-induced experimental pulmonary fibrosis.
    Nagai T; Tanaka M; Hasui K; Shirahama H; Kitajima S; Yonezawa S; Xu B; Matsuyama T
    Clin Exp Immunol; 2010 Aug; 161(2):348-56. PubMed ID: 20550546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alveolar epithelial TET2 is not involved in the development of bleomycin-induced pulmonary fibrosis.
    Qin W; Crestani B; Spek CA; Scicluna BP; van der Poll T; Duitman J
    FASEB J; 2021 May; 35(5):e21599. PubMed ID: 33913570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.